rubric: "High" meant that the reported evidence was unequivocally at the top of the scale relative to the grading system used. "Moderate" meant that the reported evidence was moderate or inconsistent. "Mixed" meant that reported evidence differed in grades by more than one grade level. For illustration, the USPSTF grading system was used for several measures. A USPSTF grade of "A" would qualify as "High" overall strength in our analysis because "A" is the top of the USPSTF scale (representing high certainty of substantial benefit). A grade of "B" would correspond to "Moderate" overall strength, because there is either high certainty of moderate benefit or moderate certainty of substantial benefit. Reported grades of "A" and "C" would be categorized as "Mixed" strength. Although we initially included a category of "Low" strength, no measures fit this category.
Of 34 measures (32 individual measures and a composite of 2 diabetes measures), 23 were NQF endorsed. The 11 nonendorsed measures included certain patient experience survey measures (n = 5), claims-based measures related to unplanned admissions and meaningful use of electronic records (n = 4), and preventive measures related to blood pressure screening and statin therapy (n = 2). Developer-reported evidence assessments were available for 16 of 23 endorsed measures. Most were process measures because outcome measures do not require formal assessment.
Differences existed in the grading systems used and the evidentiary strength. Relative to the method of grading, we categorized 7 as "High" strength, 6 as "Moderate," and 3 as "Mixed."
Based on average ACO performance, performance appeared to be lower in the moderate evidence category (overall average, 61%; range 44% to 85%) compared to the high evidence category (overall average, 77%; range 63% to 91%) (See Supplemental Table S1 , available with the online article). On the one hand, our observations reassure practicing physicians. NQF-endorsed measures undergo formal evaluation that involves assessment of the evidence base, and most are graded moderate or above. On the other hand, physicians may be concerned that not all measures are NQF endorsed or formally graded, and that the grading systems differ or may be unfamiliar.
These observations suggest ways to improve performance measurement. Our findings echo prior calls for measure endorsers to require evaluation by a standardized grading system. 5, 6 GRADE may be perceived as more rigorous and better tailored to translating evidence into practice recommendations, 7 though other systems, including the USPSTF, have advantages as well. 8 As measures increase in number and their impact grows, the case for more standardized and rigorous assessment gets stronger.
In addition, trust in performance measurement might be improved were an overall strength of evidence statement or assessment available for individual measures in a concise, user-friendly format both publicly and at the point of care. Although we were able to attain information via the raw evidence forms, this was arduous. When involved in quality improvement activities, the busy physician should be able to trust endorsement.
We hesitate to draw firm conclusions. After all, we collected information only within a single program, albeit a large and influential one. We relied on measure developers' assessment of the evidence, which may overestimate current measure evidence, and evidence is only one component of measure evaluation. NQF also evaluates measure importance, feasibility, usability, and the presence of competing measures. Past some minimal threshold, if a measure addresses a very important health issue, physicians might act on a lower level of evidentiary support. And we cannot infer causation between evidence and ACO performance, especially in light of the many behavioral influences beyond evidence alone (eg, organizational priorities, incentives, task complexity of particular measures, patient choice 9 ). Nevertheless, we believe our observations should motivate research to understand physicians' perceptions of quality measures. Prior surveys suggested that physicians question whether measures accurately reflect quality of care. 10 Explicit attention should be given to how physicians' perceptions of the evidence affect their practice patterns and their sense of professional obligation to conform to a particular measure. Quality measurement has the potential to improve patient care, but only if everyone shares a commitment to, and trust in, the measures used.
